Cell Death-Based Treatment of Glioblastoma

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-017-0021-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

NK Cell-Based Glioblastoma Immunotherapy

Cancers
Cancer ResearchOncology
2018English

Myricetin Nanoliposomes Induced SIRT3-mediated Glycolytic Metabolism Leading to Glioblastoma Cell Death

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2018English

Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death

Clinical Cancer Research
Cancer ResearchOncology
2008English

Caspase-Dependent Signaling Underlies Glioblastoma Cell Death in Response to the Fungal Metabolite, Fusarochromanone

International Journal of Molecular Medicine
MedicineGenetics
2014English

Long-Term Expression of rAAV2-hIL15 Enhances Immunoglobulin Production and Lymphokine-Activated Killer Cell-Mediated Human Glioblastoma Cell Death

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Topotecan Decreases the Expression of Programmed Death-Ligand 1 in Glioblastoma Cell Lines; Implications for Immunotherapy

Matters
2017English

The SIAH1-HIPK2-p53ser46 Damage Response Pathway Is Involved in Temozolomide-Induced Glioblastoma Cell Death

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Lauryl Gallate Induces Apoptotic Cell Death Through Caspase-Dependent Pathway in U87 Human Glioblastoma CellsIn Vitro

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

Anti-Vegf Treatment Reduces Blood Supply and Increases Tumor Cell Invasion in Glioblastoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy